Tetacept Receives FDA Orphan Drug Designation for Myasthenia Gravis (MG)
ADC评论
October 13, 2022
On October 12, Rongchang Bio announced that Taitacept (R&D code: RC18, trade name: Taiai®) was granted orphan drug designation by the U.S. Food and Drug
